Pertuzumab

CHEBI:CHEBI_748686

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Pertuzumab
rxcui
1298953
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION, CONCENTRATE
active_ingredient_strength
30 g/L
route
INTRAVENOUS
marketing_category
DRUG FOR FURTHER PROCESSING
nui
N0000020008
pharm_class_epc
HER2/neu Receptor Antagonist [EPC]
pharm_class
HER2/Neu/cerbB2 Antagonists [MoA]
pharm_class_moa
HER2/Neu/cerbB2 Antagonists [MoA]
marketing_start_date
20120608
package_marketing_start_date
08-JUN-12
labeler_name
Genentech, Inc.
manufacturer_name
Genentech, Inc.
brand_name
PERJETA
brand_name_base
PERJETA
product_ndc
67643-7003
application_number
BLA125409
spl_id
22cb73f4-ea93-2af2-e063-6394a90a84a1
active_ingredient_name
PERTUZUMAB
package_ndc
67643-7003-1
package_description
300000 mL in 1 TANK (67643-7003-1)
unii
K16AIQ8CTM
spl_set_id
17f85d17-ab71-4f5b-9fe3-0b8c822f69ff
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class